Dr. Anton Kosov, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 156 Missouri Blvd Ste B, Gravois Mills, MO 65037 Phone: 573-374-5263 Fax: 573-374-4933 |
News Archive
Senomyx, Inc., a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Firmenich SA, the world's largest privately-owned fragrance and flavor company, has made a decision to proceed with commercial development of S6973, Senomyx's enhancer of sucrose (table sugar) that has demonstrated the ability to reduce up to 50% of the sugar in a variety of products while maintaining the taste of natural sugar.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate the efficacy, tolerability and safety of pimavanserin as a treatment for patients with Parkinson's disease psychosis (PDP).
Utah Republican Gov. Gary R. Herbert has announced that the state "will join 29 other states and the District of Columbia" to run their own high-risk health insurance pools, while "[o]ther states let the federal government handle the program, concerned they would have to pay for it if they exhausted their federal funding," The Wall Street Journal reports.
UK National Health Service (NHS) figures showing a 66 percent rise in hospital admissions for men with eating disorders in England over the last 10 years are just the "tip of the iceberg," a UK charity said Wednesday.
The Aetna Foundation today announced two grants totaling $250,000 as part of its continuing efforts to establish racial and ethnic equity in health and health care. The elimination of health and health care disparities is one of three primary focus areas of the Aetna Foundation's grant-making.
› Verified 4 days ago